Unprecedented benefit seen in worldwide test of a three-drug treatment for multiple myeloma
Their findings will be reported online Dec. 6 in the New England Journal of Medicine, and presented on Dec. …
Their findings will be reported online Dec. 6 in the New England Journal of Medicine, and presented on Dec. …
source : http://www.sciencedaily.com/releases/2014/07/140716112749.htm
Although transplant specialists have been able to reduce its impact, graft-versus-host disease remains a leading cause of death among patients who receive a stem cell transplant from another person, known as an allogeneic transplant. Such transplants are used to treat blood and bone marrow cancers such as leukemia and multiple myeloma, often as a last resort…
source : http://www.foxnews.com/health/2013/06/27/drug-combo-decreases-likelihood-stroke-for-those-already-at-risk/